skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Listed as AUPH on Nasdaq. On 9/13,it establishes At-the Market Facility to sell shares up to US$40m from time to time through Jefferies.Since then the price(US$6.59) had dropped sharply to US$3.88(close on Oct 14) Results of Phase 3 on its lead drug expected by year end.My Can $8.33 p/p had dropped 34.7% to a 1% position.Please comment on the company.Also should I buy,hold or sell?Txs for u usual great services & views
Read Answer Asked by Peter on October 16, 2019
Q: I am curiuos about your take on Pharmagreen Biotech
Read Answer Asked by Jim on October 15, 2019
Q: Based on my portfolio review, I need to increase my pharmaceutical weighing. Although you do not follow US companies closely, could you give me your best recommendations for 3 US pharmaceutical Companies. My only holding at the moment is Pfizer. Could you give me your opinion on this company please?
Read Answer Asked by jacques on October 09, 2019
Q: Over several years Savaria has grown and evolved from a Canadian company to one that now operates internationally. Is Savaria's leadership evolving accordingly? Does 5i feel that Savaria has identified, and is recruiting, new people to join the Board and Senior Management with the necessary experience and skills to help guide the firm in its next stage of growth?
Read Answer Asked by Edward on October 04, 2019
Q: Currently our health sector portfolio consists of above at 1.5% each. Sector target 10%+/-. Could add to IHI and ZTS. Watch List includes SYK, GH, EXAS, CSLLY, and MPW. Would appreciate your advice on current holdings and filling out sector - either these names or others. Long-term growth goal with focus on medical technology, and diversification within sector.
Read Answer Asked by sam on October 04, 2019
Q: Dear 5i,
I am interested in speculating on this company with $1,000 to $2,000 which I am prepared to lose. Should I purchase this in my TFSA or NonReg account so I can use the tax loss if necessary? Can you explain your rationale for choosing one account over the other. I purchased Prometics awhile back and it did not turn out well. Would you say "ATE" has the same risk level as PLI?

thanks
Read Answer Asked by Ian on October 02, 2019
Q: I have shares of HLTH in a cash as well as a registered account with TD Waterhouse and noticed that they are now showing as zero value in the accounts. I assume this has to do with them being recently delisted? This is new to me. Do the shares have value? Can I trade my shares now or in the future and how do I do that if they are delisted? If the shares are worthless, how do I go about claiming the tax loss in the cash account? I am really just looking for your guidance as to what you would do in this case. Help!

I also own AGN stock which has been a terrible performer for me. It perked up when ABBV made to offer to take it over. I believe the offer was for $188.24 in ABBV stock and cash but am not sure how that works,...in calculating how much ABBV stock you get, do they use the value of the ABBV stock on the day of the offer (June 25th) or the day of the closing (likely sometime 1st Q 2020)? Do we know what % of the $188.24 will be given in stock and what will be given in cash? Initially the discussion of the purchase was neutral to negative, but I noticed that ABBV has been getting upgrades recently and the narrative may be changing. If you owned AGN stock, what would you advice be?

Thanks You

Scott
Read Answer Asked by Scott on October 01, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!